Over a week ago
Hot Stocks
Rapid7 announced it has…
Rapid7 announced it has acquired Minerva Labs, a provider of anti-evasion and ransomware prevention technology. Under the terms of the agreement, Rapid7 will pay approximately $38M in cash and stock to acquire Minerva Labs, subject to certain adjustments. The acquisition of Minerva is not expected to have a material financial impact to Rapid7's annualized recurring revenue growth, revenue, non-GAAP operating income, and non-GAAP net income per share for calendar year 2023, as guided on February 8.
Show Hide Related Items >> <<
02/13/23 Rapid7, USF partner to establish Rapid7 Cyber Threat Intelligence Lab 02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 03/12/23 Citi Citi not too concerned about systems software exposure to SVB 02/09/23 Canaccord Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook 02/09/23 Mizuho Rapid7 price target raised to $45 from $40 at Mizuho 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 02/01/23 Cybersecurity company Rapid7 explores sale, Reuters reports 02/01/23 Rapid7 exploring possible sale after attracting interest, Reuters report 02/01/23 Rapid7 exploring sale with help of advisers, Reuters reports 02/09/23 What You Missed On Wall Street On Thursday 02/09/23 What You Missed On Wall Street This Morning 02/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/01/23 What You Missed On Wall Street On Wednesday
Recommendations
Citi analyst Fatima…
Citi analyst Fatima Boolani scanned the firm's North America systems software coverage for exposure to SVB Financial (SIVB) following news of the Federal Deposit Insurance Corporation takeover at Silicon Valley Bank. SVB was the lender of choice for most of the high tech and enterprise software complex, the analyst tells investors in a research note. In Citi's initial pass of its coverage universe's filings over the last two years and SVB's documents and materials, it found Crowdstrike (CRWD), Fastly (FSLY), Rapid7 (RPD), Datadog (DDOG), SentinelOne (S), HashiCorp (HCP), and Progress Software (PRGS) as having some financial relationship with SVB. Fortinet (FTNT) noted cash deposit exposure at less than $2M, which is being transitioned out, while Crowdstrike indicated 10% of funds exposed, says Citi. At this point, the firm believes that the exposure of systems software companies "doesn't seem all that concerning."
Show Hide Related Items >> <<
03/10/23 Bank of England seeks to place Silicon Valley Bank UK into insolvency 03/10/23 Aptose Biosciences says immaterial financial exposure to Silicon Valley Bank 03/10/23 Paycor says no cash deposits or securities held at Silicon Valley Bank 03/10/23 Oncorus informs investors of holdings with SVB Financial 03/07/23 SentinelOne enters exclusive partnership with Wiz 01/12/23 SentinelOne selected by JCDC to strengthen U.S. cybersecurity 12/06/22 SentinelOne reports Q3 ARR up 106% to $487.4M 02/13/23 Rapid7, USF partner to establish Rapid7 Cyber Threat Intelligence Lab 02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 02/07/23 Progress Software completes acquisition of MarkLogic 01/19/23 Progress Software releases Progress Telerik, Progress Kendo UI 01/03/23 Progress Software to acquire MarkLogic for $355M 09/26/22 Progress Software apponts YuFan Stephanie Wang to CLO 02/23/23 HashiCorp exec sells $1.16M in common stock 02/01/23 PowerSchool appoints Paul Brook as CCO 12/07/22 HashiCorp jumps 10% to $29.43 after Q3 earnings beat and guidance raise 10/19/22 Intel announces new cloud collaboration with HashiCorp 03/07/23 Fortinet announces enhancements to FortiSASE 03/01/23 Fortinet introduces new cybersecurity products, professional services 02/08/23 Fortinet launches Cybercrime Atlas initiative 02/06/23 Fortinet announces FortiSP5 ASIC technology 02/13/23 Fastly rises 27.1% 02/13/23 Fastly rises 19.1% 02/13/23 Fastly rises 11.2% 11/15/22 Fastly director sells $3.93M in common stock 03/09/23 Datadog says all services now available unless noted otherwise 03/08/23 Datadog expects live data recovery in 'a matter of hours' 03/08/23 Datadog down 2% to $73.21 after Wells highlights major service outage 03/08/23 Datadog says making progress towards recovering all services 03/08/23 Crowdstrike CEO: We have an AI-driven model 01/17/23 Crowdstrike adds two executives to its leadership team 12/29/22 Crowdstrike director Austin buys $2.5M in company shares 12/01/22 Crowdstrike CEO: Most companies would kill for our results 03/08/23 Deutsche Bank Crowdstrike price target raised to $130 from $115 at Deutsche Bank 03/08/23 Wedbush Crowdstrike price target raised to $145 from $135 at Wedbush 03/08/23 Stifel Crowdstrike price target raised to $125 from $110 at Stifel 03/08/23 Stephens Crowdstrike price target raised to $173 from $161 at Stephens 03/12/23 BTIG BTIG finds medical technology stocks with exposure with SVB 03/12/23 Barclays Barclays reveals software names that could be impacted by SVB 03/10/23 Maxim SVB Financial downgraded to Sell from Buy at Maxim 03/10/23 Baird West Coast REITs underperforming on SVB news, says Baird 02/21/23 Citi Fastly price target raised to $8 from $7 at Citi 02/16/23 RBC Capital Fastly price target raised to $9 from $6 at RBC Capital 02/16/23 Piper Sandler Fastly price target raised to $14 from $10 at Piper Sandler 02/16/23 Craig-Hallum Craig-Hallum upgrades Fastly to Buy, sees return of 'beat/raise mode' 02/09/23 Canaccord Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook 02/09/23 Mizuho Rapid7 price target raised to $45 from $40 at Mizuho 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 03/08/23 Wells Fargo Datadog sustained major service outage today, says Wells Fargo 02/21/23 Canaccord Datadog price target lowered to $100 from $110 at Canaccord 02/21/23 BofA Datadog price target lowered to $110 from $120 at BofA 02/17/23 Mizuho Datadog price target raised to $94 from $85 at Mizuho 03/06/23 Barclays SentinelOne price target lowered to $17 from $18 at Barclays 02/21/23 Wells Fargo Wells cuts SentinelOne to Equal Weight on concerns of declining demand trends 02/21/23 Wells Fargo SentinelOne downgraded to Equal Weight from Overweight at Wells Fargo 03/10/23 Truist HashiCorp price target raised to $36 from $35 at Truist 03/10/23 TD Cowen HashiCorp price target lowered to $38 from $42 at TD Cowen 03/06/23 Needham Needham upgrades HashiCorp to Buy on conservative 2023 estimates 03/06/23 Needham HashiCorp upgraded to Buy from Hold at Needham 01/23/23 Guggenheim Progress Software assumed with a Buy at Guggenheim 09/29/22 Citi Progress Software price target lowered to $46 from $52 at Citi 09/09/22 Jefferies Progress Software initiated with a Hold at Jefferies 08/11/22 Guggenheim Progress Software initiated with a Buy at Guggenheim 02/14/23 Goldman Sachs Fortinet initiated with a Buy at Goldman Sachs 02/09/23 Loop Capital Fortinet price target raised to $80 from $66 at Loop Capital 02/09/23 Barclays Fortinet price target raised to $68 from $56 at Barclays 02/08/23 Deutsche Bank Fortinet price target raised to $63 from $53 at Deutsche Bank 03/10/23 Compugen considers exposure to SVB Financial as immaterial 01/19/23 SVB Financial reports Q4 EPS $4.62, consensus $5.27 10/20/22 SVB Financial reports Q3 EPS $7.21, consensus $6.95 12/06/22 SentinelOne sees FY23 revenue $420M-$421M, consensus $416.3M 12/06/22 SentinelOne sees Q4 revenue $125M, consensus $124.6M 12/06/22 SentinelOne reports Q3 EPS (35c), consensus (22c) 12/06/22 Notable companies reporting after market close 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 01/17/23 Progress Software sees FY23 EPS $4.09 - $4.17 , consensus $4.35 01/17/23 Progress Software sees Q1 EPS $1.04 - $1.08, consensus $1.05 01/17/23 Progress Software reports Q4 EPS $1.12, consensus $1.09 09/27/22 Progress Software raises FY22 EPS view to $4.08-$4.12 from $4.05-$4.11 03/09/23 HashiCorp sees FY24 EPS (40c)-(38c), consensus (66c) 03/09/23 HashiCorp sees Q1 EPS (15c)-(13c), consensus (19c) 03/09/23 HashiCorp reports Q4 EPS (7c), consensus (22c) 12/07/22 HashiCorp raises FY23 EPS view to (71c)-(69c) from (97c)-(95c), consensus (96c) 02/07/23 Fortinet sees FY23 EPS $1.39-$1.41, consensus $1.39 02/07/23 Fortinet sees Q1 EPS 27c-29c, consensus 27c 02/07/23 Fortinet reports Q4 EPS 44c, consensus 39c 02/07/23 Notable companies reporting after market close 02/15/23 Fastly sees FY23 EPS (27c)-(21c), consensus (44c) 02/15/23 Fastly sees Q1 EPS (12c)-(8c), consensus (12c) 02/15/23 Fastly reports Q4 EPS (8c), consensus (13c) 02/15/23 Notable companies reporting after market close 02/16/23 Datadog sees FY23 adjusted EPS $1.02-$1.09, consensus $1.15 02/16/23 Datadog reports Q1 adjusted EPS 22c-24c, consensus 24c 02/16/23 Datadog reports Q4 adjusted EPS 26c, consensus 19c 02/15/23 Notable companies reporting before tomorrow's open 03/07/23 Crowdstrike sees FY24 EPS $2.21-$2.39, consensus $2.00 03/07/23 Crowdstrike sees Q1 EPS 50c-51c, consensus 43c 03/07/23 Crowdstrike reports Q4 adjusted EPS 47c, consensus 43c 03/07/23 Notable companies reporting after market close
Conference/Events
Virtual Meeting to be…
Virtual Meeting to be held in New York on March 2 hosted by Piper Sandler.
Show Hide Related Items >> <<
02/13/23 Rapid7, USF partner to establish Rapid7 Cyber Threat Intelligence Lab 02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 02/09/23 Canaccord Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook 02/09/23 Mizuho Rapid7 price target raised to $45 from $40 at Mizuho 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 02/01/23 Cybersecurity company Rapid7 explores sale, Reuters reports 02/01/23 Rapid7 exploring possible sale after attracting interest, Reuters report 02/01/23 Rapid7 exploring sale with help of advisers, Reuters reports 02/09/23 What You Missed On Wall Street On Thursday 02/09/23 What You Missed On Wall Street This Morning 02/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/01/23 What You Missed On Wall Street On Wednesday
Over a month ago
Hot Stocks
Rapid7 is partnering with…
Rapid7 is partnering with the University of South Florida to create a cyber threat intelligence laboratory that will support interdisciplinary research efforts by faculty experts and students from four colleges and myriad disciplines. The Rapid7 Cyber Threat Intelligence Lab at USF is funded by a $1.5M investment from the Boston-based company's charitable arm, The Rapid7 Cybersecurity Foundation. This joint endeavor will catalyze new collaborative research efforts in cyber threat detection and support an inclusive approach to diverse talent development in cybersecurity. It will also provide USF students the opportunity for hands-on learning and cybersecurity skills development as well as real-world experience tracking global threat actors.
Show Hide Related Items >> <<
02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 02/09/23 Canaccord Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook 02/09/23 Mizuho Rapid7 price target raised to $45 from $40 at Mizuho 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 02/01/23 Cybersecurity company Rapid7 explores sale, Reuters reports 02/01/23 Rapid7 exploring possible sale after attracting interest, Reuters report 02/01/23 Rapid7 exploring sale with help of advisers, Reuters reports 02/09/23 What You Missed On Wall Street On Thursday 02/09/23 What You Missed On Wall Street This Morning 02/09/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 02/01/23 What You Missed On Wall Street On Wednesday
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
01/31/23 Exxon Mobil reports Q4 cash flow from operating activities $18.95B 01/30/23 Exxon Mobil awards FEED for world's largest low-carbon hydrogen facility 01/24/23 Exxon Mobil trading resumes 01/24/23 Exxon Mobil trading halted, volatility trading pause 01/10/23 Veru appoints David Ho as chairman of Scientific Advisory Board 11/09/22 Veru announces update on FDA AdCom meeting on Sabizabulin as COVID treatment 11/09/22 Veru trading halted, news pending 11/07/22 Veru jumps 32% after FDA posts briefing documents for meeting of advisors 12/04/22 Fly Intel: Top five weekend stock stories 09/09/22 Tapestry announces long-term financial targets $20.80 / +2.945 (+16.49%)
11/16/22 Sonos authorizes up to $100M stock buyback 11/16/22 Sonos names Eddie Lazarus CFO 09/09/22 USITC institutes investigation of Sonos audio players after Google complaint 08/10/22 Sonos drops 20% to $18.18 after cutting FY22 guidance, CFO change 02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 01/19/23 Purple Innovation special committee comments on Capital Management filing 01/12/23 Purple Innovation rejects unsolicited proposal from Coliseum Capital Management 12/15/22 AWH Capital urges Purple Innovation to reject Coliseum's takeover offer 11/03/22 Lovesac appoints John Legg as CSCO 02/08/23 Post Holdings to acquire select pet food brands from J.M. Smucker for $1.2B 02/08/23 J.M. Smucker to sell several pet food brands to Post Holdings for $1.2B 02/02/23 Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B 11/22/22 Post Holdings to exit ownership of BellRing Brands 02/09/23 PepsiCo sees FY23 share repurchases approximating $1B 02/09/23 PepsiCo focused on delivering at least $1B in productivity savings 02/09/23 PepsiCo: Monitoring consumers' spending patterns, behaviors 02/09/23 PepsiCo expects inflationary pressures to persist 02/08/23 New York Times sees Q1 subscription revenue up 6%-9% 12/12/22 New York Times CFO Roland Caputo to retire 11/02/22 New York Times sees Q4 subscription revenues up 17%-20% 08/11/22 New York Times jumps after ValueAct discloses 6.7% active stake 02/09/23 Globus Medical, NuVasive to combine in all-stock transaction 02/09/23 Globus Medical, NuVasive to combine in all-stock transaction 12/19/22 CubeSmart to replace NuVasive in S&P 400 at open on 12/19 12/19/22 NuVasive to replace Tupperware Brands in S&P 600 at open on 12/19 11/07/22 23andMe presents poster for expansion chohorts for 23ME-00610 10/27/22 23andMe granted FDA 510(k) clearance for PGt report for SLCO1B1 09/19/22 23andMe appoints Daniel Chu as CPO 08/19/22 23andMe CFO Steven Schoch to step down 02/08/23 Medtronic announces late-breaking clinical data from STROKE AF trial 01/30/23 Medtronic recalls Hemodialysis Catheters for leaks, FDA says 01/27/23 Orchestra BioMed begins trading on Nasdaq with cash runway into 2026 01/25/23 Medtronic recommends rejection of below-market mini-tender by TRC Capital 02/08/23 Mattel CEO: Our products are in demand and our business fundamentals are strong 02/08/23 Mattel sees FY23 capex $175M-$200M vs. $187M in FY22 02/08/23 Mattel says gross margins impacted by higher costs to manage inventory 02/08/23 Mattel falls 10% to $18.50 after Q4 earnings miss, below-consensus guidance 02/06/23 Southwest Dispatchers and Facilities Maintenance Technicians approve CBAs 02/01/23 Southwest promotes Lauren Woods to chief information officer 01/26/23 Southwest says it continues to experience year-over-year inflationary pressures 01/26/23 Southwest plans to add 7,000 workers in 2023 02/09/23 Kellogg sees FY23 tax rate 22% 02/09/23 Kellogg working towards N.A. cereal spin-off, to retain plant-based business 02/09/23 Kellogg CEO says entering 2023 in solid financial condition 01/30/23 Colgate-Palmolive names Steve Cahillane to Board of Directors 12/05/22 Hims & Hers names Scott Knoer as 1st Chief Pharmacy & Innovation Officer 11/15/22 Amazon announces 'Amazon Clinic' virtual health service 11/08/22 Hims & Hers rises 26.0% 11/08/22 Hims & Hers rises 20.1% $62.98 / -14.14 (-18.34%)
02/09/23 Globus Medical falls -17.3% 02/09/23 Globus Medical falls -14.5% 02/09/23 Globus Medical falls -14.9% 01/31/23 Nevada reports December statewide gaming win up 14.3% to $1.31B 01/30/23 Bragg Gaming launches new content with DraftKings in New Jersey 12/30/22 DraftKings to launch online sportsbook in Ohio on New Year's Day 12/29/22 Cathie Wood's ARK Investment bought 137K shares of DraftKings today $110.34 / -1.435 (-1.28%)
02/09/23 Disney announces details of strategic restructuring 02/09/23 Disney 'pleased' board can remain focused without proxy contest distraction 02/09/23 Trian concludes proxy campaign with Disney, withdraws Peltz nomination 02/09/23 Nelson Peltz says 'proxy fight is over' with Disney after last night's report 02/09/23 DHT Holdings rises 13.5% 01/09/23 DHT Holdings:Q4 time charter equivalent fleet earnings ~ $56,900 per day 09/08/22 DHT Holdings announces new dividend policy 08/29/22 DHT Holdings announces sale of DHT Edelweiss CSII Cardiovascular Systems 02/08/23 Cardiovascular Systems trading resumes 02/08/23 Cardiovascular Systems trading halted, news pending 02/09/23 Credit Suisse announces acquisition of The Klein Group LLC for $175M 02/09/23 Credit Suisse warns of 'substantial loss before taxes' for 2023 02/09/23 Credit Suisse expects to report a loss for WM, IB in Q1 02/09/23 Credit Suisse: Cost transformation 'well under way' 02/08/23 Salesforce CEO teases AI efforts, says 'get ready to be wowed' by EinsteinGPT 01/27/23 Salesforce appoints three new independent directors to board 01/22/23 Fly Intel: Top five weekend stock stories 01/12/23 Walmart enters partnership with Salesforce to provide solutions for retailers $12.33 / -3.865 (-23.87%)
10/05/22 Digital Turbine announces investment in Aptoide app store $16.11 / +3.425 (+27.00%)
02/08/23 AppLovin jumps 28% to $16.18 after Q4 results and guidance 11/30/22 AppLovin exec sells $17.6M in common stock 11/29/22 AppLovin CMO Jansen sells 48,562 class A shares 11/09/22 AppLovin says 'uniquely positioned to emerge from downturn' 11/09/22 Adidas sees 'strong' bottomline improvement in 2023 11/09/22 Adidas sees FY22 currency-neutral revenue up at a low single digit rate 11/08/22 Adidas names Bjorn Gulden as new CEO, effective January 1, 2023 11/04/22 Adidas confirms talks with Gulden as potential successor to CEO 02/06/23 Cathie Wood's ARK Investment bought 313.7K shares of Accolade today $108.06 / -2.175 (-1.97%)
02/08/23 Cardiovascular Systems jumps 43% after announcing it is being acquired by Abbott 02/08/23 Abbott to acquire Cardiovascular Systems for $20 per share, or $890M 01/26/23 Abbott: FDA approves Proclaim XR spinal cord stimulation system 01/25/23 Abbott expects $2B in covid testing in FY23 02/09/23 AbbVie says 'high level of confidence' in achieving FY23 guidance 02/09/23 AbbVie expects inflation to weigh on aesthetics business in 2023 02/09/23 AbbVie says breadth, depth of pipeline supports long term growth outlook 02/09/23 AbbVie reports Q4 global Humira net revenues $5.58B, up 4.6% on reported basis $150.95 / -0.995 (-0.65%)
02/02/23 Apple pares decline during Q1 conference call, now down 1% at $149.35 afterhours 02/02/23 Apple CFO says 'doing a lot of work on cost structure' to help gross margin 02/02/23 Apple CFO says y/y performance of Q2 to be similar to Q1 02/02/23 Apple CFO Maestri says customer satisfaction for iPhone 14 at 98% $110.34 / -1.435 (-1.28%)
02/09/23 Loop Capital Disney price target raised to $130 from $120 at Loop Capital 02/09/23 BofA Disney price target raised to $135 from $115 at BofA 02/09/23 KeyBanc Disney price target raised to $130 from $119 at KeyBanc 02/09/23 Credit Suisse Disney price target raised to $133 from $126 at Credit Suisse $108.06 / -2.175 (-1.97%)
02/09/23 Lake Street Cardiovascular Systems downgraded to Sell from Buy at Lake Street 02/07/23 Needham Surmodics price target lowered to $34 from $46 at Needham 01/27/23 Barclays Abbott price target raised to $125 from $122 at Barclays 01/26/23 Piper Sandler Abbott approval 'incremental headwind' to Nevro, says Piper Sandler CSII Cardiovascular Systems 12/21/22 Barclays Cardiovascular Systems initiated with an Equal Weight at Barclays 12/14/22 Lake Street Cardiovascular Systems initiated with a Buy at Lake Street 03/02/22 BofA Cardiovascular Systems reinstated with an Underperform at BofA 12/20/22 Atlantic Equities Coca-Cola, Pepsi remain preferred beverage names at Atlantic Equities 12/07/22 Argus PepsiCo price target raised to $206 from $195 at Argus 12/06/22 Deutsche Bank PepsiCo price target raised to $186 from $181 at Deutsche Bank 11/04/22 Redburn PepsiCo initiated with a Sell at Redburn 02/09/23 UBS J.M. Smucker upgraded to Neutral from Sell at UBS 02/07/23 Barclays Post Holdings price target raised to $105 from $102 at Barclays 02/06/23 Truist Post Holdings price target raised to $85 from $70 at Truist 01/06/23 Evercore ISI Hershey downgraded to In Line from Outperform at Evercore ISI 02/10/23 Wells Fargo Globus Medical downgraded to Equal Weight from Overweight at Wells Fargo 02/10/23 Wells Fargo NuVasive downgraded to Equal Weight from Overweight at Wells Fargo 02/10/23 Needham Needham downgrades Globus on 'meaningful' integration risks 02/10/23 Truist NuVasive downgraded to Hold from Buy at Truist $62.98 / -14.14 (-18.34%)
02/09/23 Roth MKM Roth MKM downgrades DraftKings to Sell with $15 price target 02/09/23 Roth MKM DraftKings downgraded to Sell from Neutral at Roth MKM 02/01/23 Piper Sandler DraftKings layoffs should be viewed positively, says Piper Sandler 01/23/23 Stifel DraftKings initiated with a Hold at Stifel 02/09/23 Jefferies Hims & Hers upgraded to Buy at Jefferies ahead of FY23 guidance 02/09/23 Jefferies Hims & Hers upgraded to Buy from Hold at Jefferies 01/10/23 Tigress Financial Hims & Hers price target raised to $12 from $11 at Tigress Financial 01/03/23 Piper Sandler Hims & Hers price target raised to $7 from $6 at Piper Sandler 02/09/23 Jefferies Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results 02/09/23 Jefferies Accolade downgraded to Hold from Buy at Jefferies 02/02/23 Raymond James Accolade initiated with an Outperform at Raymond James 02/01/23 Raymond James Accolade initiated with an Outperform at Raymond James 02/09/23 Canaccord Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook 02/09/23 Mizuho Rapid7 price target raised to $45 from $40 at Mizuho 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 02/09/23 Morgan Stanley New York Times price target raised to $40 from $37 at Morgan Stanley 02/09/23 Barclays New York Times upgraded to Equal Weight from Underweight at Barclays 12/16/22 Morgan Stanley New York Times downgraded to Equal Weight from Overweight at Morgan Stanley 08/11/22 Gordon Haskett New York Times share buys at UBS flagged by Gordon Haskett on activist link 02/01/23 Deutsche Bank Salesforce evaluating value options, shares have 35% upside, says Deutsche 01/30/23 Morgan Stanley Salesforce price target raised to $236 from $228 at Morgan Stanley 01/27/23 BMO Capital SAP price target raised to $125 from $110 at BMO Capital 01/23/23 Deutsche Bank Salesforce price target lowered to $190 from $200 at Deutsche Bank 02/08/23 Redburn Southwest downgraded to Neutral from Buy at Redburn 01/27/23 Deutsche Bank Southwest price target lowered to $52 from $56 at Deutsche Bank 01/27/23 TD Cowen Southwest price target lowered to $50 from $55 at Cowen 01/12/23 Barclays Southwest price target lowered to $42 from $48 at Barclays $150.95 / -0.995 (-0.65%)
02/07/23 Craig-Hallum Skyworks price target raised to $130 from $120 at Craig-Hallum 02/07/23 Credit Suisse Skyworks price target raised to $135 from $125 at Credit Suisse 02/07/23 KeyBanc Skyworks price target raised to $130 from $120 at KeyBanc 02/06/23 Credit Suisse Credit Suisse reiterates Outperform on Dell Technologies after 5% headcount cut 01/31/23 Bernstein Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein 01/24/23 Mizuho Medtronic price target lowered to $95 from $100 at Mizuho 01/09/23 RBC Capital Medtronic downgraded to Sector Perform from Outperform at RBC Capital 11/30/22 Wells Fargo Medtronic price target lowered to $77 from $82 at Wells Fargo 02/02/23 Argus Exxon Mobil price target raised to $133 from $128 at Argus 02/02/23 TD Cowen Exxon Mobil price target raised to $113 from $108 at Cowen 02/01/23 Truist Exxon Mobil price target raised to $110 from $101 at Truist 02/01/23 BofA Exxon Mobil price target raised to $140 from $136 at BofA 01/27/23 Morgan Stanley Credit Suisse resumed with an Equal Weight at Morgan Stanley 01/13/23 Barclays Credit Suisse price target lowered to CHF 2.90 from CHF 4 at Barclays 01/13/23 Deutsche Bank Credit Suisse reinstated with a Hold at Deutsche Bank 12/20/22 Exane BNP Paribas Credit Suisse resumed with an Underperform at Exane BNP Paribas $16.11 / +3.425 (+27.00%)
02/09/23 Morgan Stanley AppLovin signs of stability 'count as a win,' says Morgan Stanley 02/08/23 Credit Suisse AppLovin price target lowered to $47 from $57 at Credit Suisse 02/06/23 KeyBanc AppLovin price target lowered to $20 from $25 at KeyBanc 01/27/23 DA Davidson Playtika cut to Neutral at DA Davidson on market share loss, Rovio offer $20.80 / +2.945 (+16.49%)
10/17/22 Morgan Stanley Sonos price target lowered to $17 from $20 at Morgan Stanley 08/11/22 Morgan Stanley Sonos price target lowered to $20 from $28 at Morgan Stanley 08/11/22 Stifel Sonos price target lowered to $20 from $24 at Stifel 06/14/22 Morgan Stanley Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures 11/29/22 Jefferies DHT Holdings price target raised to $12 from $11 at Jefferies 07/20/22 Jefferies DHT Holdings initiated with a Buy at Jefferies 07/19/22 Stifel DHT Holdings price target raised to $8.50 from $7.50 at Stifel 04/27/22 Jefferies DHT Holdings reinstated with a Buy at Jefferies 11/28/22 Berenberg Berenberg starts 'well-positioned' 23andMe with a Buy 11/28/22 Berenberg 23andMe initiated with a Buy at Berenberg 09/22/22 TD Cowen 23andMe initiated with Outperform, $6 target at Cowen 09/22/22 TD Cowen 23andMe initiated with an Outperform at Cowen $12.33 / -3.865 (-23.87%)
02/09/23 Craig-Hallum Digital Turbine price target lowered to $25 from $30 at Craig-Hallum 02/09/23 Oppenheimer Oppenheimer downgrades Digital Turbine on 'unclear' long-term growth 02/09/23 Oppenheimer Digital Turbine downgraded to Perform from Outperform at Oppenheimer 02/01/23 B. Riley B. Riley downgrades Digital Turbine on app economy softness 02/10/23 H.C. Wainwright Veru price target lowered to $14 from $18 at H.C. Wainwright 12/07/22 H.C. Wainwright Veru price target lowered to $18 from $21 at H.C. Wainwright 11/10/22 H.C. Wainwright Veru price target lowered to $21 from $24 at H.C. Wainwright 09/20/22 Oppenheimer Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged' 01/16/23 BofA Purple Innovation reinstated with an Underperform at BofA 11/10/22 Craig-Hallum Purple Innovation upgraded to Buy from Hold at Craig-Hallum 09/20/22 Craig-Hallum Purple Board likely to reject Coliseum's deal, says Craig-Hallum 09/20/22 Wedbush Purple Innovation price target raised to $5 from $3.30 at Wedbush 02/10/23 Morgan Stanley Tapestry assumed with an Equal Weight at Morgan Stanley 02/10/23 Baird Tapestry price target raised to $52 from $45 at Baird 01/23/23 Barclays Capri Holdings price target raised to $72 from $56 at Barclays 01/23/23 Barclays Tapestry downgraded to Equal Weight from Overweight at Barclays 02/10/23 SVB Securities AbbVie upgraded to Market Perform from Underperform at SVB Securities 02/10/23 SVB Securities AbbVie upgraded to Market Perform from Underperform at SVB Securities 02/09/23 Piper Sandler AbbVie price target raised to $163 from $157 at Piper Sandler 02/08/23 Truist Model N price target raised to $52 from $45 at Truist 01/30/23 Deutsche Bank Kellogg price target lowered to $72 from $74 at Deutsche Bank 12/20/22 Morgan Stanley Kellogg price target raised to $74 from $72 at Morgan Stanley 11/15/22 Exane BNP Paribas Kellogg initiated with an Underperform at Exane BNP Paribas 08/08/22 RBC Capital Kellogg price target raised to $70 from $66 at RBC Capital 02/10/23 BMO Capital Mattel price target lowered to $27 from $30 at BMO Capital 02/10/23 BofA Mattel price target lowered to $21 from $26 at BofA 02/09/23 DA Davidson Mattel price target lowered to $23 from $31 at DA Davidson 01/31/23 Goldman Sachs Mattel assumed with a Buy at Goldman Sachs 02/10/23 Jefferies Adidas downgraded to Hold from Buy at Jefferies 02/03/23 Deutsche Bank Adidas price target raised to EUR 170 from EUR 160 at Deutsche Bank 01/26/23 Credit Suisse Adidas price target raised to EUR 103 from EUR 83 at Credit Suisse 01/23/23 TD Cowen Skechers upgraded to Outperform at Cowen on momentum and margin recovery 01/31/23 Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29 01/30/23 Notable companies reporting before tomorrow's open 10/28/22 Exxon Mobil reports Q3 adjusted EPS $4.45, consensus $3.79 02/09/23 Veru reports Q1 EPS (46c), consensus (38c) 12/05/22 Veru reports Q4 EPS (51c), consensus (30c) 08/11/22 Veru reports Q3 EPS (28c), consensus (18c) 02/09/23 Tapestry raises FY23 EPS view to $3.70-$3.75 from $3.60-$3.70, consensus $3.65 02/09/23 Tapestry reports Q2 EPS $1.36, consensus $1.27 $20.80 / +2.945 (+16.49%)
02/08/23 Sonos affirms FY23 revenue view of $1.7B-$1.8B, consensus $1.73B 02/08/23 Sonos reports Q1 EPS 79c, consensus 40c 11/16/22 Sonos sees FY23 revenue $1.7B-$1.8B, consensus $1.72B 11/16/22 Sonos reports Q4 adjusted EPS (32c), consensus (41c) 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 01/30/23 Purple Innovation sees FY22 net loss ($97.5M)-($83.7M) 11/09/22 Purple Innovation backs FY22 revenue view $570M-$590M, consensus $578.66M 11/09/22 Purple Innovation reports Q3 adjusted EPS 3c, consensus (5c) 02/02/23 Post Holdings reports Q1 EPS $1.52, consensus 68c 11/17/22 Post Holdings reports Q4 adjusted EPS 85c, consensus 70c 02/09/23 PepsiCo sees FY23 core EPS $7.20, consensus $7.28 02/09/23 PepsiCo sees FY23 core EPS growth 8%, consensus $7.28 02/09/23 PepsiCo reports Q4 core EPS $1.67, consensus $1.65 02/08/23 Notable companies reporting before tomorrow's open 02/08/23 New York Times reports Q4 adjusted EPS 59c, consensus 43c 11/02/22 New York Times reports Q3 adjusted EPS 21c, consensus 13c 02/09/23 NuVasive sees FY23 net sales growth 6%-8%, consensus $1.28B 02/09/23 NuVasive sees FY22 net sales growth 5.5%, consensus $1.21B 11/09/22 NuVasive lowers FY22 non-GAAP EPS to $2.00-$2.10 from $2.15-$2.45 11/09/22 NuVasive reports Q3 non-GAAP EPS 54c, consensus 54c 02/08/23 23andMe sees FY23 revenue $290M-$300M, consensus $276.59M 02/08/23 23andMe reports Q3 EPS (20c), consensus (19c) 11/07/22 23andMe sees FY23 revenue $260M-$280M, consensus $277.86M 11/07/22 23andMe reports Q2 EPS (15c), consensus (17c) 11/22/22 Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40 11/22/22 Medtronic says guidance assumes 2H23 reported revenue $15.4B-$15.6B 11/22/22 Medtronic cuts FY23 EPS view to $5.25-$5.30 from $5.53-$5.65, consensus $5.53 11/22/22 Medtronic reports Q2 EPS $1.30, consensus $1.28 02/08/23 Mattel sees FY23 adjusted EPS $1.10-$1.20, consensus $1.66 02/08/23 Mattel reports Q4 adjusted EPS 18c, consensus 29c 10/25/22 Mattel cuts FY22 EPS view to $1.32-$1.42 from $1.42-$1.48 01/26/23 Southwest sees Q1 revenue up 20%-24%, consensus $5.88B 01/26/23 Southwest reports Q4 adjusted EPS (38c), consensus (9c) 01/25/23 Notable companies reporting before tomorrow's open 02/09/23 Kellogg sees FY23 EPS down 4% to down 2% on currency neutral basis 02/09/23 Kellogg reports Q4 adjusted currency-neutral EPS 97c, consensus 84c 11/07/22 Hims & Hers raises FY22 revenue view $519M-$522M from $470M-$485M 11/07/22 Hims & Hers sees Q4 revenue $159M-$162M, consensus $134.3M 11/07/22 Hims & Hers reports Q3 EPS (9c), consensus (10c) $62.98 / -14.14 (-18.34%)
02/09/23 Globus Medical sees FY23 net sales growth 7%-8%, consensus $1.12B 02/09/23 Globus Medical sees FY22 net sales growth 6.8%, consensus $1.03B 11/08/22 Globus Medical sees FY22 EPS $2.03-$2.10, consensus $2.10 11/08/22 Globus Medical reports Q3 EPS 50c, consensus 52c 11/04/22 DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B 11/04/22 DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B 11/04/22 DraftKings reports Q3 revenue $502M, consensus $437.23M 11/03/22 Notable companies reporting before tomorrow's open $110.34 / -1.435 (-1.28%)
02/08/23 Disney reports Q1 EPS ex-items 99c, consensus 78c 02/08/23 Notable companies reporting after market close 11/08/22 Disney CFO sees FY23 cash content spend in low-$30B range 11/08/22 Disney reports Q4 EPS ex-items 30c, consensus 57c 02/08/23 DHT Holdings reports Q4 EPS 38c, consensus 30c 11/07/22 DHT Holdings reports Q3 EPS 4c, consensus (1c) 08/10/22 DHT Holdings reports Q2 EPS 6c, consensus (4c) CSII Cardiovascular Systems 02/08/23 Cardiovascular Systems reports Q2 EPS (20c), consensus (15c) 11/03/22 Cardiovascular Systems sees FY22 revenue $255M-$265M, consensus $258.48M 11/03/22 Cardiovascular Systems reports Q1 EPS (27c), consensus (23c) 02/09/23 Credit Suisse reports Q4 net revenue CHF 3.06B vs. CHF 4.58B last year 10/27/22 Credit Suisse reports Q3 net revenue CHF 3.8B vs. CHF 5.43B last year 11/30/22 Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73 11/30/22 Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34 11/30/22 Salesforce reports Q3 EPS $1.40, consensus $1.21 11/30/22 Notable companies reporting after market close $12.33 / -3.865 (-23.87%)
02/08/23 Digital Turbine sees FY23 adjusted EPS $1.15-$1.20, consensus $1.41 02/08/23 Digital Turbine reports Q3 adjusted EPS 29c, consensus 37c 11/09/22 Digital Turbine sees Q3 adjusted EPS 36c-39c, consensus 38c 11/09/22 Digital Turbine reports Q2 non-GAAP EPS 34c, consensus 33c $16.11 / +3.425 (+27.00%)
02/08/23 AppLovin sees Q1 revenue $685M-$705M, consensus $682.2M 02/08/23 AppLovin reports Q4 adjusted EBITDA up 17% at $260M 11/09/22 AppLovin cuts FY22 revenue view from $2.84B-$3.14B to $2.80B-$2.81B 02/09/23 Adidas reports preliminary 2022 sales up 1% in currency-neutral terms 02/09/23 Adidas sees 2023 currency-neutral sales down high-single-digits 11/09/22 Adidas reports Q3 revenue EUR 6.41B vs. EUR 5.752B last year 10/20/22 Adidas now expects FY22 currency neutral revenue up at mid single digit rate 01/09/23 Accolade guides initial FY24 revenue around $410M, consensus $405.4M 01/09/23 Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M 01/09/23 Accolade sees Q4 revenue $97M-$101M, consensus $101.7M 01/09/23 Accolade reports Q3 EPS (56c), consensus (62c) $108.06 / -2.175 (-1.97%)
01/25/23 Abbott sees FY23 adjusted EPS $4.30-$4.50, consensus $4.40 01/25/23 Abbott reports Q4 adjusted EPS $1.03, consensus 92c 01/24/23 Notable companies reporting before tomorrow's open 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 $150.95 / -0.995 (-0.65%)
02/02/23 Apple reports Q1 EPS $1.88, consensus $1.94 02/02/23 Notable companies reporting after market close 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close
On The Fly
Get caught up quickly on…
Show Hide Related Items >> <<
01/31/23 Exxon Mobil reports Q4 cash flow from operating activities $18.95B 01/30/23 Exxon Mobil awards FEED for world's largest low-carbon hydrogen facility 01/24/23 Exxon Mobil trading resumes 01/24/23 Exxon Mobil trading halted, volatility trading pause 01/10/23 Veru appoints David Ho as chairman of Scientific Advisory Board 11/09/22 Veru announces update on FDA AdCom meeting on Sabizabulin as COVID treatment 11/09/22 Veru trading halted, news pending 11/07/22 Veru jumps 32% after FDA posts briefing documents for meeting of advisors 12/04/22 Fly Intel: Top five weekend stock stories 09/09/22 Tapestry announces long-term financial targets $21.04 / +3.185 (+17.84%)
11/16/22 Sonos authorizes up to $100M stock buyback 11/16/22 Sonos names Eddie Lazarus CFO 09/09/22 USITC institutes investigation of Sonos audio players after Google complaint 08/10/22 Sonos drops 20% to $18.18 after cutting FY22 guidance, CFO change 01/30/23 Simply Good Foods says Geoff Tanner, named COO, CEO-elect of company 11/21/22 J.M. Smucker CEO says 'organic top-line growth across all of our businesses' 02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 01/19/23 Purple Innovation special committee comments on Capital Management filing 01/12/23 Purple Innovation rejects unsolicited proposal from Coliseum Capital Management 12/15/22 AWH Capital urges Purple Innovation to reject Coliseum's takeover offer 11/03/22 Lovesac appoints John Legg as CSCO 02/08/23 Post Holdings to acquire select pet food brands from J.M. Smucker for $1.2B 02/08/23 J.M. Smucker to sell several pet food brands to Post Holdings for $1.2B 02/02/23 Post Holdings raises FY23 adjusted EBITDA view to $1.025B-$1.065B 11/22/22 Post Holdings to exit ownership of BellRing Brands 02/09/23 PepsiCo sees FY23 share repurchases approximating $1B 02/09/23 PepsiCo focused on delivering at least $1B in productivity savings 02/09/23 PepsiCo: Monitoring consumers' spending patterns, behaviors 02/09/23 PepsiCo expects inflationary pressures to persist 02/08/23 New York Times sees Q1 subscription revenue up 6%-9% 12/12/22 New York Times CFO Roland Caputo to retire 11/02/22 New York Times sees Q4 subscription revenues up 17%-20% 08/11/22 New York Times jumps after ValueAct discloses 6.7% active stake 02/09/23 Globus Medical, NuVasive to combine in all-stock transaction 02/09/23 Globus Medical, NuVasive to combine in all-stock transaction 12/19/22 CubeSmart to replace NuVasive in S&P 400 at open on 12/19 12/19/22 NuVasive to replace Tupperware Brands in S&P 600 at open on 12/19 11/07/22 23andMe presents poster for expansion chohorts for 23ME-00610 10/27/22 23andMe granted FDA 510(k) clearance for PGt report for SLCO1B1 09/19/22 23andMe appoints Daniel Chu as CPO 08/19/22 23andMe CFO Steven Schoch to step down 02/08/23 Medtronic announces late-breaking clinical data from STROKE AF trial 01/30/23 Medtronic recalls Hemodialysis Catheters for leaks, FDA says 01/27/23 Orchestra BioMed begins trading on Nasdaq with cash runway into 2026 01/25/23 Medtronic recommends rejection of below-market mini-tender by TRC Capital $18.42 / -2.065 (-10.08%)
02/08/23 Mattel CEO: Our products are in demand and our business fundamentals are strong 02/08/23 Mattel sees FY23 capex $175M-$200M vs. $187M in FY22 02/08/23 Mattel says gross margins impacted by higher costs to manage inventory 02/08/23 Mattel falls 10% to $18.50 after Q4 earnings miss, below-consensus guidance 02/06/23 Southwest Dispatchers and Facilities Maintenance Technicians approve CBAs 02/01/23 Southwest promotes Lauren Woods to chief information officer 01/26/23 Southwest says it continues to experience year-over-year inflationary pressures 01/26/23 Southwest plans to add 7,000 workers in 2023 02/09/23 Kellogg sees FY23 tax rate 22% 02/09/23 Kellogg working towards N.A. cereal spin-off, to retain plant-based business 02/09/23 Kellogg CEO says entering 2023 in solid financial condition 01/30/23 Colgate-Palmolive names Steve Cahillane to Board of Directors 12/05/22 Hims & Hers names Scott Knoer as 1st Chief Pharmacy & Innovation Officer 11/15/22 Amazon announces 'Amazon Clinic' virtual health service 11/08/22 Hims & Hers rises 26.0% 11/08/22 Hims & Hers rises 20.1% $63.41 / -13.71 (-17.78%)
02/09/23 Globus Medical falls -17.3% 02/09/23 Globus Medical falls -14.5% 02/09/23 Globus Medical falls -14.9% 01/31/23 Nevada reports December statewide gaming win up 14.3% to $1.31B 01/30/23 Bragg Gaming launches new content with DraftKings in New Jersey 12/30/22 DraftKings to launch online sportsbook in Ohio on New Year's Day 12/29/22 Cathie Wood's ARK Investment bought 137K shares of DraftKings today $113.43 / +1.655 (+1.48%)
02/09/23 Trian concludes proxy campaign with Disney, withdraws Peltz nomination 02/09/23 Nelson Peltz says 'proxy fight is over' with Disney after last night's report 02/09/23 Disney's Iger to CNBC: Board work on sucecssor 'already underway' 02/09/23 Disney CEO Iger: 'My preference' is to stay for two years $10.25 / +1.105 (+12.08%)
02/09/23 DHT Holdings rises 13.5% 01/09/23 DHT Holdings:Q4 time charter equivalent fleet earnings ~ $56,900 per day 09/08/22 DHT Holdings announces new dividend policy 08/29/22 DHT Holdings announces sale of DHT Edelweiss CSII Cardiovascular Systems 02/08/23 Cardiovascular Systems trading resumes 02/08/23 Cardiovascular Systems trading halted, news pending 02/08/23 Salesforce CEO teases AI efforts, says 'get ready to be wowed' by EinsteinGPT 01/27/23 Salesforce appoints three new independent directors to board 01/22/23 Fly Intel: Top five weekend stock stories 01/12/23 Walmart enters partnership with Salesforce to provide solutions for retailers 02/07/23 AstraZeneca's Forxiga approved in E.U. for treatment of chronic heart failure 02/02/23 Amgen's Tezspire approved in U.S. for self-administration in severe asthma 01/26/23 AstraZeneca continuing to work with FDA to collect data on Evusheld and variants 01/26/23 FDA announces Evusheld not currently authorized for emergency use in U.S. 10/05/22 Digital Turbine announces investment in Aptoide app store $16.31 / +3.625 (+28.58%)
02/08/23 AppLovin jumps 28% to $16.18 after Q4 results and guidance 11/30/22 AppLovin exec sells $17.6M in common stock 11/29/22 AppLovin CMO Jansen sells 48,562 class A shares 11/09/22 AppLovin says 'uniquely positioned to emerge from downturn' 02/06/23 Cathie Wood's ARK Investment bought 313.7K shares of Accolade today $109.77 / -0.465 (-0.42%)
02/08/23 Cardiovascular Systems jumps 43% after announcing it is being acquired by Abbott 02/08/23 Abbott to acquire Cardiovascular Systems for $20 per share, or $890M 01/26/23 Abbott: FDA approves Proclaim XR spinal cord stimulation system 01/25/23 Abbott expects $2B in covid testing in FY23 02/09/23 AbbVie says 'high level of confidence' in achieving FY23 guidance 02/09/23 AbbVie expects inflation to weigh on aesthetics business in 2023 02/09/23 AbbVie says breadth, depth of pipeline supports long term growth outlook 02/09/23 AbbVie reports Q4 global Humira net revenues $5.58B, up 4.6% on reported basis 01/11/23 AllianceBernstein reports preliminary AUM $646B as of December 31, 2022 12/12/22 AllianceBernstein reports preliminary AUM $658B as of November 30 11/30/22 Janus Henderson names Michelle Dunstan Chief Responsibility Officer 11/22/22 AllianceBernstein, Societe Generale to form cash equities JV $153.00 / +1.055 (+0.69%)
02/02/23 Apple pares decline during Q1 conference call, now down 1% at $149.35 afterhours 02/02/23 Apple CFO says 'doing a lot of work on cost structure' to help gross margin 02/02/23 Apple CFO says y/y performance of Q2 to be similar to Q1 02/02/23 Apple CFO Maestri says customer satisfaction for iPhone 14 at 98% $153.00 / +1.055 (+0.69%)
02/07/23 Craig-Hallum Skyworks price target raised to $130 from $120 at Craig-Hallum 02/07/23 Credit Suisse Skyworks price target raised to $135 from $125 at Credit Suisse 02/07/23 KeyBanc Skyworks price target raised to $130 from $120 at KeyBanc 02/06/23 Credit Suisse Credit Suisse reiterates Outperform on Dell Technologies after 5% headcount cut 01/31/23 Bernstein Edwards Lifesciences downgraded to Underperform from Outperform at Bernstein 01/24/23 Mizuho Medtronic price target lowered to $95 from $100 at Mizuho 01/09/23 RBC Capital Medtronic downgraded to Sector Perform from Outperform at RBC Capital 11/30/22 Wells Fargo Medtronic price target lowered to $77 from $82 at Wells Fargo $113.43 / +1.655 (+1.48%)
02/09/23 Loop Capital Disney price target raised to $130 from $120 at Loop Capital 02/09/23 BofA Disney price target raised to $135 from $115 at BofA 02/09/23 KeyBanc Disney price target raised to $130 from $119 at KeyBanc 02/09/23 Credit Suisse Disney price target raised to $133 from $126 at Credit Suisse $109.77 / -0.465 (-0.42%)
02/09/23 Lake Street Cardiovascular Systems downgraded to Sell from Buy at Lake Street 02/07/23 Needham Surmodics price target lowered to $34 from $46 at Needham 01/27/23 Barclays Abbott price target raised to $125 from $122 at Barclays 01/26/23 Piper Sandler Abbott approval 'incremental headwind' to Nevro, says Piper Sandler CSII Cardiovascular Systems 12/21/22 Barclays Cardiovascular Systems initiated with an Equal Weight at Barclays 12/14/22 Lake Street Cardiovascular Systems initiated with a Buy at Lake Street 03/02/22 BofA Cardiovascular Systems reinstated with an Underperform at BofA 12/20/22 Atlantic Equities Coca-Cola, Pepsi remain preferred beverage names at Atlantic Equities 12/07/22 Argus PepsiCo price target raised to $206 from $195 at Argus 12/06/22 Deutsche Bank PepsiCo price target raised to $186 from $181 at Deutsche Bank 11/04/22 Redburn PepsiCo initiated with a Sell at Redburn 02/07/23 Barclays Post Holdings price target raised to $105 from $102 at Barclays 02/06/23 Truist Post Holdings price target raised to $85 from $70 at Truist 01/06/23 Evercore ISI Hershey downgraded to In Line from Outperform at Evercore ISI 11/29/22 Piper Sandler Post Holdings price target raised to $115 from $107 at Piper Sandler 02/09/23 Bernstein Bernstein ponders takeover targets for J.M. Smucker after pet food sale 12/20/22 Morgan Stanley J.M. Smucker upgraded to Equal Weight at Morgan Stanley on defensive positioning 12/20/22 Morgan Stanley J.M. Smucker upgraded to Equal Weight from Underweight at Morgan Stanley 12/15/22 Stifel J.M. Smucker price target raised to $155 from $148 at Stifel 02/09/23 Piper Sandler Piper downgrades NuVasive, Globus on merger agreement 02/09/23 Piper Sandler NuVasive downgraded to Neutral from Overweight at Piper Sandler 01/06/23 Needham NuVasive downgraded to Hold from Buy at Needham 11/10/22 TD Cowen NuVasive price target lowered to $50 from $65 at Cowen $63.41 / -13.71 (-17.78%)
02/09/23 Piper Sandler Globus Medical downgraded to Neutral from Overweight at Piper Sandler 01/04/23 Barclays Globus Medical price target raised to $82 from $70 at Barclays 10/18/22 Barclays Barclays starts medical devices with Positive view, Boston Scientific top pick 02/09/23 Roth MKM Roth MKM downgrades DraftKings to Sell with $15 price target 02/09/23 Roth MKM DraftKings downgraded to Sell from Neutral at Roth MKM 02/01/23 Piper Sandler DraftKings layoffs should be viewed positively, says Piper Sandler 01/23/23 Stifel DraftKings initiated with a Hold at Stifel 02/09/23 Jefferies Hims & Hers upgraded to Buy at Jefferies ahead of FY23 guidance 02/09/23 Jefferies Hims & Hers upgraded to Buy from Hold at Jefferies 01/10/23 Tigress Financial Hims & Hers price target raised to $12 from $11 at Tigress Financial 01/03/23 Piper Sandler Hims & Hers price target raised to $7 from $6 at Piper Sandler 02/09/23 Jefferies Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results 02/09/23 Jefferies Accolade downgraded to Hold from Buy at Jefferies 02/02/23 Raymond James Accolade initiated with an Outperform at Raymond James 02/01/23 Raymond James Accolade initiated with an Outperform at Raymond James 02/09/23 Canaccord Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook 02/09/23 Mizuho Rapid7 price target raised to $45 from $40 at Mizuho 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 02/09/23 Morgan Stanley New York Times price target raised to $40 from $37 at Morgan Stanley 02/09/23 Barclays New York Times upgraded to Equal Weight from Underweight at Barclays 12/16/22 Morgan Stanley New York Times downgraded to Equal Weight from Overweight at Morgan Stanley 08/11/22 Gordon Haskett New York Times share buys at UBS flagged by Gordon Haskett on activist link 02/01/23 Deutsche Bank Salesforce evaluating value options, shares have 35% upside, says Deutsche 01/30/23 Morgan Stanley Salesforce price target raised to $236 from $228 at Morgan Stanley 01/27/23 BMO Capital SAP price target raised to $125 from $110 at BMO Capital 01/23/23 Deutsche Bank Salesforce price target lowered to $190 from $200 at Deutsche Bank 02/08/23 Redburn Southwest downgraded to Neutral from Buy at Redburn 01/27/23 Deutsche Bank Southwest price target lowered to $52 from $56 at Deutsche Bank 01/27/23 TD Cowen Southwest price target lowered to $50 from $55 at Cowen 01/12/23 Barclays Southwest price target lowered to $42 from $48 at Barclays 02/02/23 Argus Exxon Mobil price target raised to $133 from $128 at Argus 02/02/23 TD Cowen Exxon Mobil price target raised to $113 from $108 at Cowen 02/01/23 Truist Exxon Mobil price target raised to $110 from $101 at Truist 02/01/23 BofA Exxon Mobil price target raised to $140 from $136 at BofA 02/07/23 Evercore ISI AllianceBernstein added to 'Tactical Outperform' list at Evercore ISI 10/18/22 Credit Suisse AllianceBernstein initiated with a Neutral at Credit Suisse 09/07/22 BofA AllianceBernstein reinstated with a Neutral at BofA 09/07/22 BofA AllianceBernstein reinstated with a Neutral at BofA $16.31 / +3.625 (+28.58%)
02/09/23 Morgan Stanley AppLovin signs of stability 'count as a win,' says Morgan Stanley 02/08/23 Credit Suisse AppLovin price target lowered to $47 from $57 at Credit Suisse 02/06/23 KeyBanc AppLovin price target lowered to $20 from $25 at KeyBanc 01/27/23 DA Davidson Playtika cut to Neutral at DA Davidson on market share loss, Rovio offer $21.04 / +3.185 (+17.84%)
10/17/22 Morgan Stanley Sonos price target lowered to $17 from $20 at Morgan Stanley 08/11/22 Morgan Stanley Sonos price target lowered to $20 from $28 at Morgan Stanley 08/11/22 Stifel Sonos price target lowered to $20 from $24 at Stifel 06/14/22 Morgan Stanley Sonos downgraded to Equal Weight at Morgan Stanley amid inflation pressures $10.25 / +1.105 (+12.08%)
11/29/22 Jefferies DHT Holdings price target raised to $12 from $11 at Jefferies 07/20/22 Jefferies DHT Holdings initiated with a Buy at Jefferies 07/19/22 Stifel DHT Holdings price target raised to $8.50 from $7.50 at Stifel 04/27/22 Jefferies DHT Holdings reinstated with a Buy at Jefferies 11/28/22 Berenberg Berenberg starts 'well-positioned' 23andMe with a Buy 11/28/22 Berenberg 23andMe initiated with a Buy at Berenberg 09/22/22 TD Cowen 23andMe initiated with Outperform, $6 target at Cowen 09/22/22 TD Cowen 23andMe initiated with an Outperform at Cowen 02/09/23 Craig-Hallum Digital Turbine price target lowered to $25 from $30 at Craig-Hallum 02/09/23 Oppenheimer Oppenheimer downgrades Digital Turbine on 'unclear' long-term growth 02/09/23 Oppenheimer Digital Turbine downgraded to Perform from Outperform at Oppenheimer 02/01/23 B. Riley B. Riley downgrades Digital Turbine on app economy softness 12/07/22 H.C. Wainwright Veru price target lowered to $18 from $21 at H.C. Wainwright 11/10/22 H.C. Wainwright Veru price target lowered to $21 from $24 at H.C. Wainwright 09/20/22 Oppenheimer Oppenheimer optimism for Veru's sabizabulin EUA remains 'unchanged' 09/08/22 Oppenheimer Oppenheimer remains bullish on Veru, optimism for EUA unchanged 01/16/23 BofA Purple Innovation reinstated with an Underperform at BofA 11/10/22 Craig-Hallum Purple Innovation upgraded to Buy from Hold at Craig-Hallum 09/20/22 Craig-Hallum Purple Board likely to reject Coliseum's deal, says Craig-Hallum 09/20/22 Wedbush Purple Innovation price target raised to $5 from $3.30 at Wedbush 01/23/23 Barclays Capri Holdings price target raised to $72 from $56 at Barclays 01/23/23 Barclays Tapestry downgraded to Equal Weight from Overweight at Barclays 12/20/22 Raymond James Tapestry initiated with an Outperform at Raymond James 12/19/22 Raymond James Tapestry initiated with an Outperform at Raymond James 02/08/23 Truist Model N price target raised to $52 from $45 at Truist 01/26/23 JPMorgan AbbVie recent weakness a buying opportunity, says JPMorgan 01/05/23 Truist AbbVie price target raised to $180 from $160 at Truist 11/17/22 Credit Suisse AbbVie initiated with an Outperform at Credit Suisse 01/30/23 Deutsche Bank Kellogg price target lowered to $72 from $74 at Deutsche Bank 12/20/22 Morgan Stanley Kellogg price target raised to $74 from $72 at Morgan Stanley 11/15/22 Exane BNP Paribas Kellogg initiated with an Underperform at Exane BNP Paribas 08/08/22 RBC Capital Kellogg price target raised to $70 from $66 at RBC Capital 01/26/23 Citi Novartis downgraded to Neutral from Buy at Citi 01/18/23 Berenberg AstraZeneca price target raised to 126 GBp from 118 GBp at Berenberg 01/12/23 Guggenheim Arvinas downgraded to Neutral at Guggenheim on rising ARV-471 risks 01/12/23 Barclays CinCor Pharma downgraded to Equal Weight from Overweight at Barclays $18.42 / -2.065 (-10.08%)
02/09/23 DA Davidson Mattel price target lowered to $23 from $31 at DA Davidson 01/31/23 Goldman Sachs Mattel assumed with a Buy at Goldman Sachs 10/26/22 DA Davidson Mattel price target lowered to $31 from $45 at DA Davidson 10/13/22 Jefferies Mattel price target lowered to $22, transferred with a Hold at Jefferies 01/31/23 Exxon Mobil reports Q4 adjusted EPS $3.40, consensus $3.29 01/30/23 Notable companies reporting before tomorrow's open 10/28/22 Exxon Mobil reports Q3 adjusted EPS $4.45, consensus $3.79 02/09/23 Veru reports Q1 EPS (46c), consensus (38c) 12/05/22 Veru reports Q4 EPS (51c), consensus (30c) 08/11/22 Veru reports Q3 EPS (28c), consensus (18c) 02/09/23 Tapestry raises FY23 EPS view to $3.70-$3.75 from $3.60-$3.70, consensus $3.65 02/09/23 Tapestry reports Q2 EPS $1.36, consensus $1.27 $21.04 / +3.185 (+17.84%)
02/08/23 Sonos affirms FY23 revenue view of $1.7B-$1.8B, consensus $1.73B 02/08/23 Sonos reports Q1 EPS 79c, consensus 40c 11/16/22 Sonos sees FY23 revenue $1.7B-$1.8B, consensus $1.72B 11/16/22 Sonos reports Q4 adjusted EPS (32c), consensus (41c) 12/14/22 J.M. Smucker backs FY23 adjusted EPS view $8.35 -$8.75, consensus $8.60 11/21/22 J.M. Smucker raises FY23 adjusted EPS view to $8.35-$8.75 from $8.20-$8.60 11/21/22 J.M. Smucker reports Q2 adjusted EPS $2.40, consensus $2.19 08/23/22 J.M. Smucker raises FY23 adjusted EPS view to $8.20-$8.60 from $7.85-$8.25 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 01/30/23 Purple Innovation sees FY22 net loss ($97.5M)-($83.7M) 11/09/22 Purple Innovation backs FY22 revenue view $570M-$590M, consensus $578.66M 11/09/22 Purple Innovation reports Q3 adjusted EPS 3c, consensus (5c) 08/09/22 Purple Innovation lowers 2022 sales outlook to $570M-$590M from $650M-$690M 02/02/23 Post Holdings reports Q1 EPS $1.52, consensus 68c 11/17/22 Post Holdings reports Q4 adjusted EPS 85c, consensus 70c 02/09/23 PepsiCo sees FY23 core EPS $7.20, consensus $7.28 02/09/23 PepsiCo sees FY23 core EPS growth 8%, consensus $7.28 02/09/23 PepsiCo reports Q4 core EPS $1.67, consensus $1.65 02/08/23 Notable companies reporting before tomorrow's open 02/08/23 New York Times reports Q4 adjusted EPS 59c, consensus 43c 11/02/22 New York Times reports Q3 adjusted EPS 21c, consensus 13c 02/09/23 NuVasive sees FY23 net sales growth 6%-8%, consensus $1.28B 02/09/23 NuVasive sees FY22 net sales growth 5.5%, consensus $1.21B 11/09/22 NuVasive lowers FY22 non-GAAP EPS to $2.00-$2.10 from $2.15-$2.45 11/09/22 NuVasive reports Q3 non-GAAP EPS 54c, consensus 54c 02/08/23 23andMe sees FY23 revenue $290M-$300M, consensus $276.59M 02/08/23 23andMe reports Q3 EPS (20c), consensus (19c) 11/07/22 23andMe sees FY23 revenue $260M-$280M, consensus $277.86M 11/07/22 23andMe reports Q2 EPS (15c), consensus (17c) 11/22/22 Medtronic sees Q3 adjusted EPS $1.25-$1.27, consensus $1.40 11/22/22 Medtronic says guidance assumes 2H23 reported revenue $15.4B-$15.6B 11/22/22 Medtronic cuts FY23 EPS view to $5.25-$5.30 from $5.53-$5.65, consensus $5.53 11/22/22 Medtronic reports Q2 EPS $1.30, consensus $1.28 $18.42 / -2.065 (-10.08%)
02/08/23 Mattel sees FY23 adjusted EPS $1.10-$1.20, consensus $1.66 02/08/23 Mattel reports Q4 adjusted EPS 18c, consensus 29c 10/25/22 Mattel cuts FY22 EPS view to $1.32-$1.42 from $1.42-$1.48 01/26/23 Southwest sees Q1 revenue up 20%-24%, consensus $5.88B 01/26/23 Southwest reports Q4 adjusted EPS (38c), consensus (9c) 01/25/23 Notable companies reporting before tomorrow's open 02/09/23 Kellogg sees FY23 EPS down 4% to down 2% on currency neutral basis 02/09/23 Kellogg reports Q4 adjusted currency-neutral EPS 97c, consensus 84c 11/07/22 Hims & Hers raises FY22 revenue view $519M-$522M from $470M-$485M 11/07/22 Hims & Hers sees Q4 revenue $159M-$162M, consensus $134.3M 11/07/22 Hims & Hers reports Q3 EPS (9c), consensus (10c) $63.41 / -13.71 (-17.78%)
02/09/23 Globus Medical sees FY23 net sales growth 7%-8%, consensus $1.12B 02/09/23 Globus Medical sees FY22 net sales growth 6.8%, consensus $1.03B 11/08/22 Globus Medical sees FY22 EPS $2.03-$2.10, consensus $2.10 11/08/22 Globus Medical reports Q3 EPS 50c, consensus 52c 11/04/22 DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B 11/04/22 DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B 11/04/22 DraftKings reports Q3 revenue $502M, consensus $437.23M 11/03/22 Notable companies reporting before tomorrow's open $113.43 / +1.655 (+1.48%)
02/08/23 Disney reports Q1 EPS ex-items 99c, consensus 78c 02/08/23 Notable companies reporting after market close 11/08/22 Disney CFO sees FY23 cash content spend in low-$30B range 11/08/22 Disney reports Q4 EPS ex-items 30c, consensus 57c $10.25 / +1.105 (+12.08%)
02/08/23 DHT Holdings reports Q4 EPS 38c, consensus 30c 11/07/22 DHT Holdings reports Q3 EPS 4c, consensus (1c) 08/10/22 DHT Holdings reports Q2 EPS 6c, consensus (4c) CSII Cardiovascular Systems 02/08/23 Cardiovascular Systems reports Q2 EPS (20c), consensus (15c) 11/03/22 Cardiovascular Systems sees FY22 revenue $255M-$265M, consensus $258.48M 11/03/22 Cardiovascular Systems reports Q1 EPS (27c), consensus (23c) 11/30/22 Salesforce raises FY23 EPS view to $4.92-$4.94, consensus $4.73 11/30/22 Salesforce sees Q4 EPS $1.35-$1.37, consensus $1.34 11/30/22 Salesforce reports Q3 EPS $1.40, consensus $1.21 11/30/22 Notable companies reporting after market close 02/09/23 AstraZeneca sees FY23 core EPS up high single to low double-digit percentage 02/09/23 AstraZeneca reports Q4 core EPS $1.38, consensus $1.35 11/10/22 AstraZeneca raises FY22 core EPS view to high 20s to low 30s percentage 11/10/22 AstraZeneca reports Q3 core EPS $1.67, YTD core EPS $5.28 02/08/23 Digital Turbine sees FY23 adjusted EPS $1.15-$1.20, consensus $1.41 02/08/23 Digital Turbine reports Q3 adjusted EPS 29c, consensus 37c 11/09/22 Digital Turbine sees Q3 adjusted EPS 36c-39c, consensus 38c 11/09/22 Digital Turbine reports Q2 non-GAAP EPS 34c, consensus 33c $16.31 / +3.625 (+28.58%)
02/08/23 AppLovin sees Q1 revenue $685M-$705M, consensus $682.2M 02/08/23 AppLovin reports Q4 adjusted EBITDA up 17% at $260M 11/09/22 AppLovin cuts FY22 revenue view from $2.84B-$3.14B to $2.80B-$2.81B 01/09/23 Accolade guides initial FY24 revenue around $410M, consensus $405.4M 01/09/23 Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M 01/09/23 Accolade sees Q4 revenue $97M-$101M, consensus $101.7M 01/09/23 Accolade reports Q3 EPS (56c), consensus (62c) $109.77 / -0.465 (-0.42%)
01/25/23 Abbott sees FY23 adjusted EPS $4.30-$4.50, consensus $4.40 01/25/23 Abbott reports Q4 adjusted EPS $1.03, consensus 92c 01/24/23 Notable companies reporting before tomorrow's open 02/09/23 AbbVie sees Q1 adjusted EPS $2.39-$2.49, consensus $3.08 02/09/23 AbbVie sees FY23 revenue about $52B, consensus $54.21B 02/09/23 AbbVie sees FY23 adjusted EPS $10.70-$11.10, consensus $11.65 02/09/23 AbbVie reports Q4 adjusted EPS $3.60, consensus $3.56 02/08/23 AllianceBernstein reports Q4 adjusted EPS 70c, consensus 57c 10/28/22 AllianceBernstein reports Q3 adjusted EPS 64c, consensus 57c $153.00 / +1.055 (+0.69%)
02/02/23 Apple reports Q1 EPS $1.88, consensus $1.94 02/02/23 Notable companies reporting after market close 10/27/22 Apple reports Q4 EPS $1.29, consensus $1.17 10/27/22 Notable companies reporting after market close
On The Fly
Show Hide Related Items >> <<
01/10/23 RMI launches virtual power plant partnership with GM, Google, Ford 01/05/23 SunPower, Maxeon Solar extend current supply relationship 11/10/22 California issues revised proposal on rooftop solar subsidies 11/07/22 Notable companies reporting before tomorrow's open 01/17/23 Crowdstrike adds two executives to its leadership team 01/12/23 SentinelOne selected by JCDC to strengthen U.S. cybersecurity 12/06/22 SentinelOne reports Q3 ARR up 106% to $487.4M 11/30/22 SentinelOne falls -10.9% 02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 02/08/23 New York Times sees Q1 subscription revenue up 6%-9% 12/12/22 New York Times CFO Roland Caputo to retire 11/02/22 New York Times sees Q4 subscription revenues up 17%-20% 08/11/22 New York Times jumps after ValueAct discloses 6.7% active stake KPRX Kiora Pharmaceuticals 02/09/23 Kiora Pharmaceuticals received IND approval for Phase 2 study of KIO-101 01/03/23 Kiora Pharmaceuticals completes enrollment in PCED study for KIO-201 10/18/22 Kiora Pharmaceuticals Inc trading resumes 10/18/22 Kiora Pharmaceuticals Inc trading halted, volatility trading pause 02/08/23 Chase to hire over 500 small business bankers through 2024 01/20/23 JPMorgan Asset Management receives approval for 100% ownership of China JV 01/13/23 JPMorgan says continues to expect 17% ROTCE in 2023 01/13/23 JPMorgan says targeting potential $12B in share buybacks in 2023 12/05/22 Hims & Hers names Scott Knoer as 1st Chief Pharmacy & Innovation Officer 11/15/22 Amazon announces 'Amazon Clinic' virtual health service 11/08/22 Hims & Hers rises 26.0% 11/08/22 Hims & Hers rises 20.1% 12/15/22 Emcore announces sale, leaseback of Tinley Park facility 12/06/22 Emcore introduces new TAC-450 Inertial Measurement Units 09/15/22 Emcore to showcase product portfolio at ION GNSS+ 08/22/22 Direct Digital appoints Maria Vilchez as Chief Growth Officer 01/31/23 Nevada reports December statewide gaming win up 14.3% to $1.31B 01/30/23 Bragg Gaming launches new content with DraftKings in New Jersey 12/30/22 DraftKings to launch online sportsbook in Ohio on New Year's Day 12/29/22 Cathie Wood's ARK Investment bought 137K shares of DraftKings today 02/07/23 Cerence enhances driving experience for Mercedes-Benz tour guide feature 01/09/23 Cerence announces BYD to deploy its conversational AI in BYD EVs worldwide 01/04/23 Cerence announces continued strategic partnership with what3words 12/14/22 Cerence enters partnerships with iHeartMedia, Radioline 12/05/22 Coupang director sells $7.47M in common stock 12/05/22 Coupang falls -7.4% 11/09/22 Coupang reports Q3 active customers up 7% y/y 02/08/23 BofA to offer residential EV charger financing alongside auto loans 02/06/23 Bank of America exec Koder sells 214,745 common shares 01/13/23 Bank of America sees mid-single digit loan growth next year 01/13/23 Bank of America sees Q1 NII around $14.4B 02/08/23 Affirm sinks 18% to $13.02 after Q2 miss, outlook reduction 02/08/23 Affirm cuts 2023 outlook amid macroeconomic headwinds 02/08/23 Affirm sees $77M-$83M in annualized cost savings 02/08/23 Affirm to reduce workforce by 19%, effective today 02/06/23 Cathie Wood's ARK Investment bought 313.7K shares of Accolade today 02/09/23 Morgan Stanley New York Times price target raised to $40 from $37 at Morgan Stanley 02/09/23 Barclays New York Times upgraded to Equal Weight from Underweight at Barclays 12/16/22 Morgan Stanley New York Times downgraded to Equal Weight from Overweight at Morgan Stanley 08/11/22 Gordon Haskett New York Times share buys at UBS flagged by Gordon Haskett on activist link 02/09/23 Canaccord Rapid7 downgraded to Hold at Canaccord on 'soft' 2023 outlook 02/09/23 Mizuho Rapid7 price target raised to $45 from $40 at Mizuho 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 02/09/23 Roth MKM Roth MKM downgrades DraftKings to Sell with $15 price target 02/09/23 Roth MKM DraftKings downgraded to Sell from Neutral at Roth MKM 02/01/23 Piper Sandler DraftKings layoffs should be viewed positively, says Piper Sandler 01/23/23 Stifel DraftKings initiated with a Hold at Stifel 02/09/23 Jefferies Hims & Hers upgraded to Buy at Jefferies ahead of FY23 guidance 02/09/23 Jefferies Hims & Hers upgraded to Buy from Hold at Jefferies 01/10/23 Tigress Financial Hims & Hers price target raised to $12 from $11 at Tigress Financial 01/03/23 Piper Sandler Hims & Hers price target raised to $7 from $6 at Piper Sandler 02/09/23 Jefferies Accolade downgraded to Hold at Jefferies after 'lukewarm' survey results 02/09/23 Jefferies Accolade downgraded to Hold from Buy at Jefferies 02/02/23 Raymond James Accolade initiated with an Outperform at Raymond James 02/01/23 Raymond James Accolade initiated with an Outperform at Raymond James 02/09/23 Northland Emcore upgraded to Outperform at Northland on potential cable optics sale 02/09/23 Lake Street Emcore upgraded to Buy at Lake Street with CATV business at bottom 02/09/23 Lake Street Emcore upgraded to Buy from Hold at Lake Street 02/09/23 Northland Emcore upgraded to Outperform from Market Perform at Northland 02/09/23 Craig-Hallum Craig-Hallum upgrades Cerence to Buy, ups price target to $40 02/09/23 Craig-Hallum Cerence upgraded to Buy from Hold at Craig-Hallum 02/09/23 Wells Fargo Cerence price target raised to $32 from $25 at Wells Fargo 02/09/23 Baird Cerence price target raised to $30 from $23 at Baird KPRX Kiora Pharmaceuticals 02/09/23 Maxim Kiora Pharmaceuticals upgraded to Buy at Maxim after IND approval for KIO-101 02/09/23 Maxim Kiora Pharmaceuticals upgraded to Buy from Hold at Maxim 02/07/23 Ladenburg Ladenburg reiterates Buy on Kiora following Phase 2 KIO-101 OPRA+ IND clearance 01/03/23 Ladenburg Kiora Pharmaceuticals completes enrollment in Phase 2 study, says Ladenburg 02/08/23 Keefe Bruyette Keefe Bruyette downgrades 'vulnerable' Bank of America to Underperform 02/08/23 Keefe Bruyette Bank of America downgraded to Underperform at Keefe Bruyette 01/31/23 Atlantic Equities Bank of America downgraded to Neutral from Overweight at Atlantic Equities 01/24/23 BofA Banks' potential new online wallet unlikely to threaten PayPal, says BofA 01/17/23 Citi JPMorgan price target raised to $165 from $150 at Citi 01/17/23 Piper Sandler JPMorgan price target raised to $157 from $150 at Piper Sandler 02/09/23 Deutsche Bank Affirm price target lowered to $12 from $18 at Deutsche Bank 02/09/23 DA Davidson Affirm price target lowered to $20 from $24 at DA Davidson 02/09/23 RBC Capital RBC Capital cuts Affirm to Sector Perform on higher funding costs, slower sales 02/09/23 Truist Affirm price target lowered to $17 from $21 at Truist 02/09/23 Barclays Coupang initiated with an Overweight at Barclays 12/01/22 New Street Coupang initiated with a Buy at New Street 11/29/22 Bernstein Coupang not gaining market share fast enough, says Bernstein 10/07/22 HSBC Coupang initiated with a Buy at HSBC 02/09/23 Canaccord Canaccord starts 'long-term secular winner' SentinelOne with Buy 02/09/23 Canaccord SentinelOne initiated with a Buy at Canaccord 01/24/23 JPMorgan SentinelOne initiated with an Overweight at JPMorgan 01/23/23 Guggenheim SentinelOne initiated with a Buy at Guggenheim 02/09/23 Janney Montgomery Scott Janney starts SunPower at Neutral with $16 fair value estimate 02/09/23 Janney Montgomery Scott SunPower initiated with a Neutral at Janney Montgomery Scott 01/25/23 Barclays SunPower downgraded to Underweight from Equal Weight at Barclays 01/17/23 Deutsche Bank SunPower price target raised to $21 from $16 at Deutsche Bank 02/09/23 EF Hutton Direct Digital initiated with a Buy at EF Hutton 07/12/22 Noble Capital Direct Digital initiated with an Outperform at Noble Capital 03/28/22 Roth MKM Direct Digital initiated with a Buy at Roth Capital 03/08/22 Benchmark Benchmark starts 'unique asset' in ad-tech Direct Digital at Buy 02/09/23 Raymond James Vertex initiated with an Outperform at Raymond James 02/08/23 Raymond James Vertex initiated with an Outperform at Raymond James 01/05/23 Jefferies Vertex downgraded to Hold from Buy at Jefferies 10/21/22 Citi Vertex price target raised to $16 from $15 at Citi 11/09/22 Vertex sees Q4 revenue $124M-$127M, consensus $125.19M 11/09/22 Vertex sees FY22 revenue $484.5M-$487.5M, consensus $482.11M 11/09/22 Vertex reports Q3 non-GAAP EPS 8c, consensus 6c 11/08/22 SunPower backs FY22 adjusted EBITDA view $90M-$110M 11/08/22 SunPower reports Q3 adjusted cont ops EPS 13c, consensus 8c 12/06/22 SentinelOne sees FY23 revenue $420M-$421M, consensus $416.3M 12/06/22 SentinelOne sees Q4 revenue $125M, consensus $124.6M 12/06/22 SentinelOne reports Q3 EPS (35c), consensus (22c) 12/06/22 Notable companies reporting after market close 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 02/08/23 New York Times reports Q4 adjusted EPS 59c, consensus 43c 11/02/22 New York Times reports Q3 adjusted EPS 21c, consensus 13c 01/13/23 JPMorgan reports Q4 EPS $3.57, consensus $3.07 10/14/22 JPMorgan reports Q3 EPS $3.12, consensus $2.88 11/07/22 Hims & Hers raises FY22 revenue view $519M-$522M from $470M-$485M 11/07/22 Hims & Hers sees Q4 revenue $159M-$162M, consensus $134.3M 11/07/22 Hims & Hers reports Q3 EPS (9c), consensus (10c) 02/08/23 Emcore sees Q2 revenue $$27M$29M, two-estimates $27.5M 02/08/23 Emcore reports Q1 EPS (22c), two-estimates (21c) 12/21/22 Emcore sees Q1 revenue $25M-$27M, consensus $30.86M 12/21/22 Emcore reports Q4 adjusted EPS (29c), consensus (17c) 11/10/22 Direct Digital raises FY22 revenue view to $85M-$90M from $70M-$75M 11/10/22 Direct Digital reports Q3 EPS 6c, consensus 5c 08/11/22 Direct Digital raises FY22 revenue view to $70M-$75M, consensus $51.9M 08/11/22 Direct Digital reports Q2 EPS 18c, consensus 6c 11/04/22 DraftKings sees 2023 revenue $2.8B-$3B, consensus $2.83B 11/04/22 DraftKings raises 2022 revenue view $2.16B-$2.19B from $2.08B-$2.18B 11/04/22 DraftKings reports Q3 revenue $502M, consensus $437.23M 11/03/22 Notable companies reporting before tomorrow's open 02/08/23 Cerence sees FY23 revenue $275M-$290M, consensus $280.71M 02/08/23 Cerence sees Q2 revenue $64M-$68M, consensus $68.25M 02/08/23 Cerence reports Q1 EPS adjusted 36c, consensus 9c 11/29/22 Cerence targets FY24 revenue of $385M, FY26 revenue of $515M 11/09/22 Coupang reports Q3 EPS 5c, consensus (3c) 08/10/22 Coupang raises FY22 adjusted EBITDA view 08/10/22 Coupang reports Q2 EPS (4c), consensus (11c) 01/13/23 Bank of America reports Q4 EPS 85c, consensus 77c 01/12/23 Notable companies reporting before tomorrow's open 10/17/22 Bank of America reports Q3 EPS 81c, consensus 77c 02/08/23 Affirm sees FY23 revenue $1.475B-$1.55B, consensus $1.64B 02/08/23 Affirm sees Q3 revenue $360M-$380M, consensus $417.96M 02/08/23 Affirm reports Q2 EPS ($1.10), consensus (98c) 02/08/23 Notable companies reporting after market close 01/09/23 Accolade guides initial FY24 revenue around $410M, consensus $405.4M 01/09/23 Accolade narrows FY23 revenue view to $361M-$365M, consensus $359.2M 01/09/23 Accolade sees Q4 revenue $97M-$101M, consensus $101.7M 01/09/23 Accolade reports Q3 EPS (56c), consensus (62c)
Downgrade
As previously reported,…
As previously reported, Canaccord analyst T. Michael Walkley downgraded Rapid7 to Hold from Buy with a price target of $52, down from $55, following the company's quarterly report. While Q4 results were "solid" in light of sustained macro challenges, the "soft" 2023 outlook was below expectations as the company anticipates macro pressures to persist throughout the year, the analyst tells investors. The firm believes Rapid7 has strong expansion opportunities within its customer base and "a long runway to drive net customer adds," but is moving to the sidelines following the softer-than-anticipated guidance.
Show Hide Related Items >> <<
02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 02/09/23 Mizuho Rapid7 price target raised to $45 from $40 at Mizuho 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 02/09/23 Piper Sandler Rapid7 downgraded to Neutral from Overweight at Piper Sandler 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 02/01/23 Cybersecurity company Rapid7 explores sale, Reuters reports 02/01/23 Rapid7 exploring possible sale after attracting interest, Reuters report 02/01/23 Rapid7 exploring sale with help of advisers, Reuters reports 02/01/23 What You Missed On Wall Street On Wednesday 02/01/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/03/22 What You Missed On Wall Street On Thursday
Recommendations
Mizuho analyst Gregg…
Mizuho analyst Gregg Moskowitz raised the firm's price target on Rapid7 to $45 from $40 and keeps a Neutral rating on the shares. The company reported "lackluster" Q4 results and initiated an "even more guarded" 2023 outlook versus the "disappointing" preliminary expectations provided 90 days ago, the analyst tells investors in a research note. The firm believes the recent execution issues pertaining to Rapid7's go-to-market strategy aren't easily solvable.
Show Hide Related Items >> <<
02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 02/09/23 Baird Rapid7 price target lowered to $56 from $58 at Baird 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 02/09/23 Piper Sandler Rapid7 downgraded to Neutral from Overweight at Piper Sandler 02/09/23 Barclays Rapid7 price target raised to $58 from $37 at Barclays 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 02/01/23 Cybersecurity company Rapid7 explores sale, Reuters reports 02/01/23 Rapid7 exploring possible sale after attracting interest, Reuters report 02/01/23 Rapid7 exploring sale with help of advisers, Reuters reports 02/01/23 What You Missed On Wall Street On Wednesday 02/01/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/03/22 What You Missed On Wall Street On Thursday
Recommendations
Baird analyst Shrenik…
Baird analyst Shrenik Kothari lowered the firm's price target on Rapid7 to $56 from $58 and keeps an Outperform rating on the shares. The analyst said 4Q results were better than feared, fueled by platform growth and early success with the bundled GTM motion.
Show Hide Related Items >> <<
02/01/23 Rapid7 trading resumes 02/01/23 Rapid7 trading halted, volatility trading pause 09/22/22 Rapid7 enters multi-year partnership with The Bruins 02/09/23 Raymond James Rapid7 price target raised to $55 from $50 at Raymond James 02/09/23 Piper Sandler Rapid7 downgraded to Neutral from Overweight at Piper Sandler 02/09/23 Barclays Rapid7 price target raised to $58 from $37 at Barclays 02/09/23 Canaccord Rapid7 downgraded to Hold from Buy at Canaccord 02/08/23 Rapid7 guides initial FY23 EPS 81c-88c, consensus 49c 02/08/23 Rapid7 sees Q1 EPS 7c-10c, consensus 7c 02/08/23 Rapid7 reports Q4 EPS 35c, consensus 18c 11/02/22 Rapid7 sees FY22 EPS 17c-20c, consensus 11c 02/01/23 Cybersecurity company Rapid7 explores sale, Reuters reports 02/01/23 Rapid7 exploring possible sale after attracting interest, Reuters report 02/01/23 Rapid7 exploring sale with help of advisers, Reuters reports 02/01/23 What You Missed On Wall Street On Wednesday 02/01/23 What You Missed On Wall Street This Morning 01/24/23 Street Wrap: Today's Top 15 Upgrades, Downgrades, Initiations 11/03/22 What You Missed On Wall Street On Thursday
